BeiGene Ltd. (BGNE)
NASDAQ: BGNE
· Real-Time Price · USD
184.71
0.90 (0.49%)
At close: Dec 31, 2024, 10:00 PM
0.49% (1D)
| Bid | 180.03 |
| Market Cap | 20.21B |
| Revenue (ttm) | 4.56B |
| Net Income (ttm) | -177.64M |
| EPS (ttm) | -8.19 |
| PE Ratio (ttm) | -22.553113553113555 |
| Forward PE | 53.69 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 189.93 |
| Volume | 329,397 |
| Avg. Volume (20D) | 357,765 |
| Open | 184.00 |
| Previous Close | 183.81 |
| Day's Range | 183.91 - 187.42 |
| 52-Week Range | 126.97 - 248.16 |
| Beta | 0.63 |
| Ex-Dividend Date | n/a |
About BGNE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BGNE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BGNE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBeiGene Ltd. is scheduled to release its earnings on
Feb 24, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
10 months ago
+7.31%
BioGene shares are trading higher after the compan...
Unlock content with
Pro Subscription
10 months ago
-5.56%
BeiGene shares are trading lower. The company reported Q3 financial results.